Corporate Information | Press & Media | For Investors

[VIDEO] New Study Results: Severity scoring system to identify patient risk for genetic conditions

by

Development and implementation of an automated severity scoring system to identify patients at possible increased risk for specific genetic conditions NSGC 2021 Poster UM353

[Press Release] ThinkGenetic Announces Integration of Innovative Diagnostic Aid in Takeda Pilot Awareness Initiative

by

ThinkGenetic, Inc. is set to launch three disease-specific versions of the diagnostic aid, SymptomMatcher™ for upcoming pilot awareness initiatives by global biopharmaceutical leader, Takeda Pharmaceutical Company Limited.

Together let’s systematically accelerate detecting at-risk  individuals.

Request a Demo

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

ThinkGenetic does not provide medical advice, diagnosis or treatment. Click here for more information.